Economy News Why Weight Loss Drugs Like Ozempic Are A Game Changer For The Global Economy

Ozempic 2.0! Experts call GLP-1 pills a game-changer for weight loss—here's how they work and when to expect them

Imagine if losing weight were as simple as swallowing a daily pill-no needles, no injections and no anxiety. If you're among the 25 percent of adults who fear needles, per Harvard Health, or if ... Read More

Ozempic’s Latest Weight Loss Competition Is Like Nothing We’ve Seen Before

In an early human trial, Eli Lilly's eloralintide helped people lose up to 20% of their body weight. Reading time 3 minutes The race to develop the next generation of weight loss drugs has taken an ... Read More

WHO recommends Ozempic-style weight loss drugs for obesity

Obesity affects more than 1 billion people worldwide and is recognized by the World Health Organization as a chronic, relapsing disease associated with substantial morbidity, mortality, and economic ... Read More

Weight-loss drugs will go global

Drugs that treat diabetes and weight loss have become a commercial and cultural phenomenon. But supply shortages and eye-watering prices have kept slimming jabs largely confined to the rich world, ... Read More

Ozempic-type drugs are here to stay, and they’re reshaping the global consumer economy

When was the last time a prescription drug changed how entire nations eat, shop, travel, dress and spend? According to a Harvard Business Review analysis by Ali Furman of PwC’s U.S. consumer markets ... Read More

Ozempic is changing how we spend money and time, plus what we eat

Warning: This graphic requires JavaScript. Please enable JavaScript for the best experience. Industry insiders are gearing up for weight-loss drugs to shake up the ... Read More

A second helping of weight-loss drugs is coming

The appetite for weight-loss drugs, known as glp-1 agonists, has been insatiable since they hit the market a decade ago. In 2024 global spending on them reached $54bn, a figure that is sure to rise in ... Read More

Medicare to Cover GLP-1 Drugs for as Little as $50 a Month Under Trump Plan

Diccon Hyatt is an experienced financial and economics reporter. He's written hundreds of articles breaking down complex financial topics in plain language, emphasizing the impact that economic ... Read More

More Americans use weight loss drugs like Ozempic than live in Texas

O. Rose Broderick reports on the health policies and technologies that govern people with disabilities’ lives. Before coming to STAT, she worked at WNYC’s Radiolab and Scientific American, and her ... Read More

Why Weight-Loss Drug Prices Are Falling

President Trump claimed credit Thursday for cutting prices on popular weight-loss drugs by Eli Lilly and Novo Nordisk. Sorry to spoil the celebration, but market competition probably would achieve the ... Read More